Place of the novel drug ranolazine in the treatment of coronary artery disease
Despite the widely used myocardial revascularization (angioplasty and stenting, aorto- or mammo-coronary bypass), extensive pharmacotherapy aimed at improving the quality of life (through the improvement of exercise tolerance and elimination of angina attacks) and increasing its "quantity"...
Main Authors: | GA Baryshnikova, SA Chorbinskaya, II Stepanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/686 |
Similar Items
-
Ranolazine: Multifaceted role beyond coronary artery disease, a recent perspective
by: Gopal Chandra Ghosh, et al.
Published: (2018-01-01) -
RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01) -
EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01) -
Sravnenie gemodinamicheskikh i biokhimicheskikh effektov karvedilola i atenolola i ikh vliyanie na prognoz u bol'nykh sakharnym diabetom 2 tipa, perenesshikh epizod nestabil'noy stenokardii
by: L A Ivanova, et al.
Published: (2008-06-01) -
A case of vasospastic angina. Vasospasm physiopathology: a new therapeutic role for ranolazine?
by: Carlo Uran, et al.
Published: (2020-08-01)